Systemic metabolic dysfunction drives platelet-mediated inflammation, fibrogenesis, and hepatocarcinogenesis in metabolic dysfunction-associated steatotic liver disease

Bingjie Ye, Chengfu Xu · 2026

Read Systemic metabolic dysfunction drives platelet-mediated inflammation, fibrogenesis, and hepatocarcinogenesis in metabolic dysfunction-associated steatotic liver disease by Bingjie Ye, Chengfu Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13430363.txt.

Description

Bingjie Ye and Chengfu Xu published a 2026 review on the role of platelets in fatty liver disease tied to metabolic problems. This liver disease is now the most common chronic liver disease in the world. Platelets are best known for stopping bleeding, but they also shape inflammation and immune responses.

The review pulls together what is known about how metabolic strain and gut imbalance make platelets overactive and draw them into the liver. Once there, platelets worsen fat buildup and swelling. They also push scar tissue growth by switching on star shaped liver cells, and they may help liver cancer form. The authors weigh whether drugs that calm platelets could slow the disease, a use beyond their heart care role.

Catalog record

CREATORBingjie Ye, Chengfu Xu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE76 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13430363

Browse the full library · About the Tower of Babel